Literature DB >> 27435408

Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management.

Michael A Valentino1, Andrew Panakos2, Loheetha Ragupathi2, Janna Williams2, Behzad B Pavri3,2.   

Abstract

In the setting of flecainide toxicity, supraventricular tachycardia can manifest as a bizarre right or left bundle branch block, sometimes with a northwest axis, and can easily be mistaken for ventricular tachycardia leading to inappropriate therapy. We conducted a comprehensive literature review for cases of flecainide toxicity. We found 21 articles of flecainide toxicity in adult patients in which 22 ECG tracings were published. In patients with flecainide toxicity and QRS duration ≤ 200 ms, the ECGs were more likely to show RBBB, visible P waves (p = 0.03), and shorter QT (p = 0.02) and QTc intervals (p = 0.004). With QRS duration > 200 ms, the ECGs were more likely to show LBBB, loss of P waves, a northwest axis (p = 0.01), and longer QT and QTc intervals. Deaths were reported only in patients with QRS duration >200 ms, and the outcome of death or requirement for mechanical circulatory support was more prevalent in patients with a QRS duration > 200 ms [2/13 (15.4 %) vs. 6/10 (60 %), p = 0.04]. In patients with access to the medication, flecainide toxicity should be suspected with: (1) broad QRS, (2) RBBB morphology with QRS ≤ 200 ms; RBBB or LBBB morphology with QRS ≥ 200 ms (3) HR out of proportion to the degree of hemodynamic instability. The duration of the QRS interval is prognostic, with mortality and the requirement for mechanical circulatory support being more common in patients with a QRS > 200 ms.

Entities:  

Keywords:  Electrocardiogram; Flecainide; Toxicity/overdose

Mesh:

Substances:

Year:  2017        PMID: 27435408     DOI: 10.1007/s12012-016-9380-0

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  6 in total

Review 1.  Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia.

Authors:  Isabelle Malhamé; Christy Gandhi; Gofran Tarabulsi; Matthew Esposito; Kristin Lombardi; Antony Chu; Kenneth K Chen
Journal:  Obstet Med       Date:  2018-11-15

2.  Flecainide toxicity associated with the use of goji berries: a case report.

Authors:  Carlos E Guzmán; Carla Gabriela Guzmán-Moreno; José Luis Assad-Morell; Edgar Francisco Carrizales-Sepúlveda
Journal:  Eur Heart J Case Rep       Date:  2021-06-01

3.  A Case Report of Flecainide Toxicity With Review of Literature.

Authors:  Pratik Khatiwada; Lindsey Clark; Arjun Khunger; Bhimesh B Rijal; Jody Ritter
Journal:  Cureus       Date:  2022-02-15

4.  Flecainide toxicity in renal tubular acidosis type IV treated with extracorporeal membrane oxygenation.

Authors:  Salima Ahmed Bhimani; Sruti Rao; Holly Nadorlik; Elizabeth V Saarel; Peter F Aziz
Journal:  HeartRhythm Case Rep       Date:  2020-02-10

5.  Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.

Authors:  Sarah E Gardner Yelton; James B Leonard; Caridad M de la Uz; Rajeev S Wadia; Sean S Barnes
Journal:  Case Rep Crit Care       Date:  2021-05-13

Review 6.  Flecainide toxicity: a presentation to the emergency department with literature review.

Authors:  Rashpal Ghataoura; Shashank Patil
Journal:  BMJ Case Rep       Date:  2020-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.